Omni Health, Inc.
OMHE · OTC
4/30/2017 | 4/30/2016 | 4/30/2015 | 4/30/2014 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.09 | -0.01 | 0.00 | 0.00 |
| FCF Yield | -1.41% | -3.75% | -0.23% | 0.00% |
| EV / EBITDA | 20.77 | -6.65 | -306.67 | 0.00 |
| Quality | ||||
| ROIC | 7.47% | 410.19% | 85.23% | 0.00% |
| Gross Margin | 33.07% | 12.87% | 45.07% | 0.00% |
| Cash Conversion Ratio | -0.03 | 0.25 | 0.55 | – |
| Growth | ||||
| Revenue 3-Year CAGR | 132.00% | 597,749.71% | 721,665.22% | -100.00% |
| Free Cash Flow Growth | -165.94% | -484.94% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 1.14 | 0.04 | 2.18 | 0.00 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 8.27 | 6.99 | 7.56 | 0.00 |
| Cash Conversion Cycle | 102.01 | 56.35 | 45.62 | 0.00 |